ClinicalTrials.gov
ClinicalTrials.gov Menu

Clinical Trial Comparing Gemcitabine and Vandetanib Therapy With Gemcitabine Alone in Pancreatic Carcinoma (ViP)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01601808
Recruitment Status : Unknown
Verified May 2012 by Dr Gary MIddleton, University of Liverpool.
Recruitment status was:  Recruiting
First Posted : May 18, 2012
Last Update Posted : May 18, 2012
Sponsor:
Collaborator:
AstraZeneca
Information provided by (Responsible Party):
Dr Gary MIddleton, University of Liverpool

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Unknown
  Estimated Primary Completion Date : October 2012
  Estimated Study Completion Date : October 2013